Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators.

Chakka N, Andrews KL, Berry LM, Bregman H, Gunaydin H, Huang L, Guzman-Perez A, Plant MH, Simard JR, Gingras J, DiMauro EF.

Eur J Med Chem. 2017 Sep 8;137:63-75. doi: 10.1016/j.ejmech.2017.05.036. Epub 2017 May 12.

PMID:
28575722
2.

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity.

Graceffa RF, Boezio AA, Able J, Altmann S, Berry LM, Boezio C, Butler JR, Chu-Moyer M, Cooke M, DiMauro EF, Dineen TA, Feric Bojic E, Foti RS, Fremeau RT Jr, Guzman-Perez A, Gao H, Gunaydin H, Huang H, Huang L, Ilch C, Jarosh M, Kornecook T, Kreiman CR, La DS, Ligutti J, Milgram BC, Lin MJ, Marx IE, Nguyen HN, Peterson EA, Rescourio G, Roberts J, Schenkel L, Shimanovich R, Sparling BA, Stellwagen J, Taborn K, Vaida KR, Wang J, Yeoman J, Yu V, Zhu D, Moyer BD, Weiss MM.

J Med Chem. 2017 Jul 27;60(14):5990-6017. doi: 10.1021/acs.jmedchem.6b01850. Epub 2017 Apr 20.

PMID:
28324649
3.

Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.

DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM.

J Med Chem. 2016 Sep 8;59(17):7818-39. doi: 10.1021/acs.jmedchem.6b00425. Epub 2016 Aug 29.

PMID:
27441383
4.

Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.

Berry LM, Liu J, Colletti A, Krolikowski P, Zhao Z, Teffera Y.

Drug Metab Dispos. 2014 Apr;42(4):707-17. doi: 10.1124/dmd.113.054809. Epub 2014 Jan 14.

PMID:
24423753
5.

Dynamic modeling of cytochrome P450 inhibition in vitro: impact of inhibitor depletion on IC₅₀ shift.

Berry LM, Zhao Z, Lin MH.

Drug Metab Dispos. 2013 Jul;41(7):1433-41. doi: 10.1124/dmd.113.051508. Epub 2013 May 6.

PMID:
23649703
6.

Impact of hydrolysis-mediated clearance on the pharmacokinetics of novel anaplastic lymphoma kinase inhibitors.

Teffera Y, Berry LM, Brake RL, Lewis RT, Saffran DC, Moore E, Liu J, Zhao Z.

Drug Metab Dispos. 2013 Jan;41(1):238-47. doi: 10.1124/dmd.112.047993. Epub 2012 Nov 1.

PMID:
23118327
7.

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.

Munro TA, Berry LM, Van't Veer A, Béguin C, Carroll FI, Zhao Z, Carlezon WA Jr, Cohen BM.

BMC Pharmacol. 2012 May 29;12:5. doi: 10.1186/1471-2210-12-5.

8.

Species differences in distribution and prediction of human V(ss) from preclinical data.

Berry LM, Li C, Zhao Z.

Drug Metab Dispos. 2011 Nov;39(11):2103-16. doi: 10.1124/dmd.111.040766. Epub 2011 Aug 18.

PMID:
21852367
9.

Less food for thought. Impact of attentional instructions on intrusive thoughts about snack foods.

May J, Andrade J, Batey H, Berry LM, Kavanagh DJ.

Appetite. 2010 Oct;55(2):279-87. doi: 10.1016/j.appet.2010.06.014. Epub 2010 Jun 30.

PMID:
20600411
10.

Prediction of V(ss) from in vitro tissue-binding studies.

Berry LM, Roberts J, Be X, Zhao Z, Lin MH.

Drug Metab Dispos. 2010 Jan;38(1):115-21. doi: 10.1124/dmd.109.029629.

PMID:
19797608
11.

Emotional and behavioral reaction to intrusive thoughts.

Berry LM, May J, Andrade J, Kavanagh D.

Assessment. 2010 Mar;17(1):126-37. doi: 10.1177/1073191109344694. Epub 2009 Oct 1.

PMID:
19797324
12.

Esterase activities in the blood, liver and intestine of several preclinical species and humans.

Berry LM, Wollenberg L, Zhao Z.

Drug Metab Lett. 2009 Apr;3(2):70-7.

PMID:
19601867
13.

In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.

Berry LM, Adams R, Airey M, Bracher MG, Bourne T, Carrington B, Cross AS, Davies GC, Finney HM, Foulkes R, Gozzard N, Griffin RA, Hailu H, Lamour SD, Lawson AD, Lightwood DJ, McKnight AJ, O'Dowd VL, Oxbrow AK, Popplewell AG, Shaw S, Stephens PE, Sweeney B, Tomlinson KL, Uhe C, Palframan RT.

Int Immunopharmacol. 2009 Feb;9(2):201-6. doi: 10.1016/j.intimp.2008.11.001. Epub 2008 Nov 27.

PMID:
19041426
15.

Preference for a stimulus that follows a relatively aversive event: contrast or delay reduction?

Singer RA, Berry LM, Zentall TR.

J Exp Anal Behav. 2007 Mar;87(2):275-85.

16.
18.

Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans.

Cook CS, Berry LM, Bible RH, Hribar JD, Hajdu E, Liu NW.

Drug Metab Dispos. 2003 Nov;31(11):1448-55.

PMID:
14570778
19.

Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.

Cook CS, Berry LM, Kim DH, Burton EG, Hribar JD, Zhang L.

Drug Metab Dispos. 2002 Dec;30(12):1344-51.

PMID:
12433801
20.

Antenatal glucocorticoids alter premature newborn lamb neuroendocrine and endocrine responses to hypoxia.

Ervin MG, Padbury JF, Polk DH, Ikegami M, Berry LM, Jobe AH.

Am J Physiol Regul Integr Comp Physiol. 2000 Sep;279(3):R830-8.

21.

Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis.

Epperly MW, Bray JA, Krager S, Berry LM, Gooding W, Engelhardt JF, Zwacka R, Travis EL, Greenberger JS.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):169-81.

PMID:
9989524
22.

Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep.

Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG.

Am J Obstet Gynecol. 1998 May;178(5):880-5.

PMID:
9609554
23.

Premature "closing" of the foramen ovale in transposition of the great arteries with intact ventricular septum: rare cause of sudden neonatal death.

Berry LM, Padbury J, Novoa-Takara L, Emmanouilides GC.

Pediatr Cardiol. 1998 May-Jun;19(3):246-8.

PMID:
9568223
24.

Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone.

Berry LM, Polk DH, Ikegami M, Jobe AH, Padbury JF, Ervin MG.

Am J Physiol. 1997 Jun;272(6 Pt 2):R1972-9.

PMID:
9227616
25.

Single dose fetal betamethasone administration stabilizes postnatal glomerular filtration rate and alters endocrine function in premature lambs.

Ervin MG, Berry LM, Ikegami M, Jobe AH, Padbury JF, Polk DH.

Pediatr Res. 1996 Nov;40(5):645-51.

PMID:
8910927
26.

Bystander injury of host lymphoid tissue during murine graft-verus-host disease is mediated by nitric oxide.

Hoffman RA, Langrehr JM, Berry LM, White DA, Schattenfroh NC, McCarthy SA, Simmons RL.

Transplantation. 1996 Feb 27;61(4):610-8.

PMID:
8610389
27.

Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section.

Padbury JF, Polk DH, Ervin MG, Berry LM, Ikegami M, Jobe AH.

Pediatr Res. 1995 Nov;38(5):709-15.

PMID:
8552438
28.

Postnatal renal adaptation in preterm and term lambs.

Berry LM, Ikegami M, Woods E, Ervin MG.

Reprod Fertil Dev. 1995;7(3):491-8.

PMID:
8606960
29.

Realistic expectations of the labor coach.

Berry LM.

J Obstet Gynecol Neonatal Nurs. 1988 Sep-Oct;17(5):354-5.

PMID:
3225684
30.
31.

Confidentiality and ACC.

Berry LM.

N Z Med J. 1979 Feb 14;89(629):97-8. No abstract available.

PMID:
155787
32.

Rethinking our goals for integrated health services.

Berry LM.

J Natl Med Assoc. 1966 Jul;58(4):291 passim. No abstract available.

Supplemental Content

Loading ...
Support Center